PT Suparma (SPMA) Fundamentals 2026 — P/E 6.0x, Revenue Analysis | SniperIQ
PT Suparma (SPMA) is a ID-listed Basic Materials company in Paper, Lumber & Forest Products with a market capitalization of Rp906.2B, trading at Rp170.00 on the JKT. This SniperIQ fundamentals page covers PT Suparma's valuation (P/E 6.0x, P/B 0.3x), profitability (net margin 3.7%), revenue (Rp2.74T in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.
Full research coverage
- 8-Quarter Revenue & Margin Trend
- Debt Maturity & Coverage
- Peer Valuation Comparison
- Free Cash Flow & Owner Earnings
- AI Signal + Institutional Flow
- DCF Valuation Model
Frequently Asked Questions
What is PT Suparma's market cap?
PT Suparma (SPMA) has a market capitalization of approximately Rp906.2B, trading at Rp170.00 on the JKT. Market cap moves with the live share price.
What is PT Suparma's P/E ratio?
PT Suparma's trailing twelve-month P/E ratio is 6.0x, with a price-to-book (P/B) of 0.3x. Valuation multiples are best compared with Basic Materials sector peers rather than read in isolation.
How profitable is PT Suparma?
PT Suparma runs a net profit margin of 3.7%, a gross margin of 15.1%, and an operating margin of 6.7%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
How much revenue does PT Suparma generate?
PT Suparma reported revenue of Rp2.74T for fiscal year 2025, with net income of Rp106.2B and earnings per share (EPS) of 25.91. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.
Does PT Suparma pay a dividend?
PT Suparma does not currently show a material trailing dividend yield; it is positioned more as a total-return name. Always confirm the latest dividend policy in the company's filings.
Is PT Suparma financially healthy?
PT Suparma carries a debt-to-equity ratio of 0.31x and a current ratio of 1.90x, with a market beta of 0.54. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
Is PT Suparma a good stock to buy in 2026?
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For PT Suparma (SPMA) the key facts are: market cap Rp906.2B, P/E 6.0x, revenue Rp2.74T, 52-week range 136.92308-260.35504. Weigh valuation, profitability, growth, and balance-sheet strength against Basic Materials peers and form your own view.
Track PT Suparma's full fundamentals live
Get PT Suparma's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.